fashion -WSS

fashion

author：hotspot 2025-10-03 01:04:05 - browse：72534

Sammy Kimball for STAT

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.

For more on what we cover, here’s the latest on Merck; here’s more from ASCO; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： FDA poised to publish guidelines for clinical trial diversity

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Fentanyl is making it harder to start addiction treatment

Rise in cancer among younger people worries and puzzles doctors

Will the FTC rein in IQVIA's health data empire?

Liver decline slowed by off

New Alzheimer's drugs heat up race for early detection blood tests

focus

fashion

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Search called off for baby washed away in Pennsylvania flash flood

Heart attack and stroke risk calculators need revising

UHS says company favors patients whose insurance pays more

Medical records are filled with copy

Listen: A conversation with researcher Kevin Esvelt on biosecurity

State Dept. review finds Biden bears some blame for Afghanistan failures

Will the FTC rein in IQVIA's health data empire?

The high cost of giving birth even with insurance

Making the case for fair compensation in clinical trials

leisure time

'Investigate these claims': UFO transparency at center of House hearing

Truvian presents data for its desktop blood

A new crop of companies is reshaping the health data economy

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

How doctors’ personal politics affect patients

UHS says company favors patients whose insurance pays more

entertainment

leisure time

hotspot

knowledge